 With intraperitoneal injection, tyloxapol also blocks plasma lipolytic activity, and thus the breakdown of triglyceride-rich lipoproteins.This mechanism is used to induce experimental hyperlipidemia in animals.Tyloxapol is the main active ingredient of the medical device Tacholiquin.